Quintet Private Bank (Europe)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Sell
10,713
-45,312
-81% -$2.46M 0.03% 83
2026
Q1
$3.52M Buy
56,025
+24,731
+79% +$1.98M 0.24% 40
2025
Q4
$2.98M Buy
31,294
+8,931
+40% +$876K 0.17% 47
2025
Q3
$2.18M Sell
22,363
-300
-1% -$31.1K 0.12% 58
2025
Q2
$2.43M Buy
22,663
+1,736
+8% +$176K 0.14% 55
2025
Q1
$2.11M Buy
20,927
+170
+0.8% +$17.1K 0.12% 63
2024
Q4
$1.85M Sell
20,757
-2,824
-12% -$249K 0.1% 63
2024
Q3
$1.98M Buy
23,581
+4,914
+26% +$387K 0.11% 64
2024
Q2
$1.64M Buy
18,667
+1,864
+11% +$136K 0.1% 69
2024
Q1
$1.32M Buy
16,803
+16,603
+8,302% +$1.07M 0.06% 85
2023
Q4
$11.6K Hold
200
﹤0.01% 174
2023
Q3
$10.6K Sell
200
-1
-0.5% -$52 ﹤0.01% 199
2023
Q2
$10.8K Buy
201
+1
+0.5% +$52 ﹤0.01% 219
2023
Q1
$10K Buy
+200
New +$9.43K ﹤0.01% 241
2022
Q2
$10.8K Buy
+201
New +$8.18K ﹤0.01% 219

Other funds holding BSX

Quintet Private Bank (Europe)'s BSX Position: Q2 2026 in Review

Quintet Private Bank (Europe) reduced its Boston Scientific (BSX) stake by 81% in Q2 2026, selling an estimated $2.46M and leaving 10,713 shares worth $457K. The position accounts for 0.03% of the portfolio, ranked #83.

Quintet Private Bank (Europe) first reported a position in BSX in Q2 2022 and has held it in 15 quarters since. The position peaked at $3.52M in Q1 2026. 366 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Quintet Private Bank (Europe) held 10,713 shares of Boston Scientific worth $457K as of Q2 2026.
  • Quintet Private Bank (Europe) sold 45,312 Boston Scientific shares in Q2 2026, an estimated $2.46M.
  • Boston Scientific made up 0.03% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #83 holding.
  • Quintet Private Bank (Europe) first reported a position in Boston Scientific in Q2 2022 and has held it in 15 quarters since.
  • Quintet Private Bank (Europe)'s Boston Scientific position peaked at $3.52M in Q1 2026.
  • 366 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.